JB

John Ballew

Search and Evaluation Lead, Oncology, Takeda Pharmaceuticals

Boston, Massachusetts

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

2021

  • Search and Evaluation Lead, Oncology, Takeda Pharmaceuticals

    2023

  • Academic Innovation Lead (Oncology), Takeda Pharmaceuticals

    2021 - 2023

2021 - 2021

  • Sr Associate

    2021 - 2021

2017 - 2021

  • Associate Director, R&D Business Development, Takeda Pharmaceuticals

    2020 - 2021

  • Senior Manager, R&D Business Development, Takeda Pharmaceuticals

    2019 - 2020

  • Senior Manager, Scientific & Competitive Analysis, Takeda Oncology

    2018 - 2019

  • Manager, Scientific & Competitive Analysis, Takeda Oncology

    2017 - 2018

2015 - 2017

  • Consultant

    2017 - 2017

  • Life Sciences Consultant

    2015 - 2016

2015 - 2015

  • VentureLabs Fellow

    2015 - 2015

  • Postdoctoral Associate

    2013 - 2015

  • Business Development Intern

    2012 - 2013

    • Performed market research and competitive intelligence in the areas of molecular diagnostics and biological therapeutics; reported to CTO on a weekly basis. • Assessed the funding and partnership/alliance landscape for ten biotechnology companies and developed basic financial forecasts using financial data for each company; evaluated biological therapeutic markets in numerous autoimmune disease franchises to support strategic-decision making in new disease area entry. • Conducted intellectual property searches to aid in applications development.

2006 - 2013

  • PhD, Biomolecular Science & Engineering

    2006 - 2013

    • Received degree in the UCSB Graduate Program in Management Practice, a business degree program designed to educate engineering-oriented PhD candidates in the areas of high-tech business management and entrepreneurship. • Completed two primary research studies on the development of antibody-based molecular diagnostics, resulting in one first author paper (PNAS) and co-first author paper (in submission); also published as contributing author (Nanotechnology for Chemical and Biological Defense). • A patent was filed and a start-up company was founded (Serimmune, Inc.) based on the PNAS paper methodology, 2014. • PNAS paper ranks in the top 5% of all articles ever tracked by Altmetric and currently ranks in the 98th percentile (out of 2,204,423 articles); PNAS research study was featured in two popular press articles in 2013. • Won Best Oral Presentation Award at the University of California Systemwide Bioengineering Symposium, 2013. • Awarded a Whitaker International Fellowship for Biomedical Engineers and studied at the Royal Institute of Technology in Stockholm, Sweden under Drs. Jochen Schwenk and Johan Rockberg (2010-2011). • Received 2010 UCSB Chang Fellowship for Outstanding Research in Biochemistry/Molecular Biology, 2 awarded in 2010. • Final GPA: 3.91/4.0

  • Visiting Research Scholar

    2010 - 2011

  • Undergraduate Research Assistant

    2004 - 2006

    • Awarded consecutive annual Undergraduate Research Fellowships to fund primary research projects in the labs of Drs. John McDevitt and Jon Robertus, 2004 - 2006. • Nominated by faculty to serve as Undergraduate Research Journal Selection Board member, 25 students selected across UT Austin campus, 2005. • Elected to Marketing Director and Vice Presidential positions in the American Chemical Society affiliate chapter, 2003-2005. • UT Austin Arnold Beckman Scholarship Finalist, 2005.